New operating chief at Neurocrine; shares up 5% premarket

|About: Neurocrine Biosciences... (NBIX)|By:, SA News Editor

Neurocrine Biosciences (NASDAQ:NBIX) appoints David-Alexander Gros, M.D., as President and Chief Operating Officer. He joins the firm from Alnylam Pharmaceuticals (NASDAQ:ALNY) where he was SVP, Chief Business Officer.

Shares are up 5% premarket on modest volume.

Subscribe for full text news in your inbox